Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX)
12. Februar 2024 22:28 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals, Inc.
Muscular Dystrophy Association Announces Collaboration with Mitsubishi Tanabe Pharma America for Remote Digital Technology Research Study for Amyotrophic Lateral Sclerosis (ALS)
30. Oktober 2023 09:01 ET
|
Muscular Dystrophy Association
New York, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) and Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced their collaboration for a remote observational...
Muscular Dystrophy Association Kicks Off 30 Days of Strength Campaign for National Muscular Dystrophy Awareness Month in September
28. August 2023 09:00 ET
|
Muscular Dystrophy Association
New York, Aug. 28, 2023 (GLOBE NEWSWIRE) -- September marks the Muscular Dystrophy Association’s (MDA) kick-off of "National Muscular Dystrophy Awareness Month," to raise awareness and critical...
Muscular Dystrophy Association International Association of Fire Fighters Launch 420 Fill the Boot Fundraisers in Cities Across America Labor Day Weekend for the Muscular Dystrophy Association
21. August 2023 13:01 ET
|
Muscular Dystrophy Association
New York, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) in partnership with the International Association of Fire Fighters (IAFF) today kick off more than 420 Fill the...
Registration Now Open for 2024 MDA Clinical & Scientific Conference, to Showcase Cutting Edge Research Advancements and Clinical Achievements in Neuromuscular Disease
09. August 2023 10:35 ET
|
Muscular Dystrophy Association
New York, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA), convener of the largest worldwide gathering of the neuromuscular disease community, announced today that...
ABC Eyewitness News Anchor Bill Ritter to Host Muscular Dystrophy Association’s 23rd Annual Wings Over Wall Street Gala to Benefit ALS Research, Honoring Dr. Angela Genge, Lisa Galante, R.N., Susan Jaycox
18. Mai 2023 11:23 ET
|
Muscular Dystrophy Association
New York, May 18, 2023 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association's (MDA) 23rd annual Wings Over Wall Street (WOWS) gala, will be held Thursday, June 1 at 6pm at The Edison Ballroom in New...
Amydis Announces Enrollment of First Participants in PROBE, a Phase 1/2a Trial Evaluating a Novel Retinal Tracer in People with Amyotrophic Lateral Sclerosis or Parkinson’s Disease
22. September 2022 07:00 ET
|
Amydis, Inc.
SAN DIEGO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of diagnostic drug candidates targeting CNS biomarkers in the eye, today...
Amydis Receives NIH Grant Award to Develop a Novel TDP-43 Retinal Tracer in Patients with ALS and FTD
18. August 2022 07:00 ET
|
Amydis, Inc.
SAN DIEGO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
Amydis Appoints Dr. Robert N. Weinreb as First Chair of Scientific Advisory Board
04. April 2022 07:00 ET
|
Amydis, Inc.
SAN DIEGO, April 04, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a healthcare company developing a new class of molecular retinal diagnostics and digital biomarkers to accelerate the early detection and...